Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | February 29, 2016 | March 03, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 29, 2016 · Filed March 03, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 354,517 |
Ending reported balance
After 2016-02-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-02-29 · Tax withholding · Disposed 15,087 · Balance 357,603 Row 2 · 2016-02-29 · Sale · Disposed 3,086 · Balance 354,517 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 29, 2016 Filed Mar 3, 2016 00:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,086 | $39.28 | $121,221.17 |
DisclosureSEC source: 0001179110-16-020733 · edgar.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,517 Read SEC document |
| February 29, 2016 Filed Mar 3, 2016 00:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 15,087 | $39.52 | $596,238.24 |
DisclosureSEC source: 0001179110-16-020733 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,603 Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 313,926 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019904 · edgar.xml · derivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,926 Underlying: Common shares · 313,926 shares Expires 2026-02-18 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 104,642 on 02/19/2017, 104,642 on 02/19/2018, and 104,642 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 35,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019904 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,690 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 18,529 | $47.61 | $882,165.69 |
DisclosureSEC source: 0001179110-15-004032 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,883 Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:32 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 157,421 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003319 · edgar.xml · derivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,421 Underlying: Common shares · 157,421 shares Expires 2025-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 52,474 on 2/20/16, 52,473 on 2/20/17, and 52,474 on 2/20/18. Read SEC document |
| February 20, 2015 Filed Feb 24, 2015 22:32 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 22,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-003319 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,412 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,600 | $39.00 | $62,406.40 |
DisclosureSEC source: 0001179110-14-004309 · edgar.xml · nonDerivative · entry 3 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,072 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 498 | $39.00 | $19,423.00 |
DisclosureSEC source: 0001179110-14-004309 · edgar.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,672 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 22,004 | $39.79 | $875,539.16 |
DisclosureSEC source: 0001179110-14-004309 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,170 Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 134,741 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003612 · edgar.xml · derivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,741 Underlying: Common shares · 134,741 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 44,914 on 2/21/2015, 44,913 on 2/21/2016, and 44,914 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 22,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003612 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,174 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 28, 2013 Filed Mar 2, 2013 00:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 18,984 | $34.26 | $650,391.84 |
DisclosureSEC source: 0001179110-13-003907 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,165 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,772 | $34.79 | $96,440.65 |
DisclosureSEC source: 0001179110-13-003129 · edgar.xml · nonDerivative · entry 5 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,149 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $34.79 | $3,479.12 |
DisclosureSEC source: 0001179110-13-003129 · edgar.xml · nonDerivative · entry 4 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,921 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,800 | $34.79 | $62,625.60 |
DisclosureSEC source: 0001179110-13-003129 · edgar.xml · nonDerivative · entry 3 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,021 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 13,572 | $35.08 | $476,105.76 |
DisclosureSEC source: 0001179110-13-003129 · edgar.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,821 Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 63,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003129 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,393 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 17,073 | $57.04 | $973,843.92 |
DisclosureSEC source: 0001179110-12-004076 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,993 Read SEC document |
| February 17, 2012 Filed Feb 22, 2012 23:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 42,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-003257 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,066 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 28, 2011 Filed Mar 2, 2011 22:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,534 | $47.91 | $73,498.54 |
DisclosureSEC source: 0001179110-11-003906 · edgar.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,366 Read SEC document |
| February 28, 2011 Filed Mar 2, 2011 22:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 17,131 | $47.64 | $816,120.84 |
DisclosureSEC source: 0001179110-11-003906 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,900 Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 43,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003263 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,031 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 19,542 | $54.12 | $1,057,613.04 |
DisclosureSEC source: 0001179110-10-004243 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,931 Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003593 · edgar.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,473 F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 35,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-003593 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,473 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,100 | $53.93 | $113,257.20 |
DisclosureSEC source: 0001179110-10-003158 · edgar.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,973 Read SEC document |
| February 16, 2010 Filed Feb 18, 2010 23:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,474 | $53.93 | $349,142.82 |
DisclosureSEC source: 0001179110-10-003158 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,073 Read SEC document |
| February 27, 2009 Filed Mar 3, 2009 16:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 13,309 | $50.58 | $673,169.22 |
DisclosureSEC source: 0001104659-09-013732 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,547 Read SEC document |
| February 20, 2009 Filed Feb 24, 2009 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 47,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-09-011813 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,856 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2009 Filed Feb 19, 2009 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,834 | $54.41 | $99,791.61 |
DisclosureSEC source: 0001104659-09-010780 · a4.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,456 Read SEC document |
| February 17, 2009 Filed Feb 19, 2009 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 5,457 | $54.94 | $299,807.58 |
DisclosureSEC source: 0001104659-09-010780 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,290 Read SEC document |
| February 29, 2008 Filed Mar 5, 2008 01:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 7,259 | $54.22 | $393,582.98 |
DisclosureSEC source: 0001104659-08-015205 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,747 Read SEC document |
| February 19, 2008 Filed Feb 20, 2008 23:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,634 | $56.06 | $91,603.67 |
DisclosureSEC source: 0001104659-08-011828 · a4.xml · nonDerivative · entry 5 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,006 Read SEC document |
| February 19, 2008 Filed Feb 20, 2008 23:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $56.06 | $11,212.00 |
DisclosureSEC source: 0001104659-08-011828 · a4.xml · nonDerivative · entry 4 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,640 Read SEC document |
| February 18, 2008 Filed Feb 20, 2008 23:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 4,011 | $55.55 | $222,811.05 |
DisclosureSEC source: 0001104659-08-011828 · a4.xml · nonDerivative · entry 3 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,840 Read SEC document |
| February 17, 2008 Filed Feb 20, 2008 23:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,579 | $55.55 | $365,463.45 |
DisclosureSEC source: 0001104659-08-011828 · a4.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,851 Read SEC document |
| February 15, 2008 Filed Feb 20, 2008 23:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 46,000 | $55.56 | $2,555,760.00 |
DisclosureSEC source: 0001104659-08-011828 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,430 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2007 Filed Feb 20, 2007 21:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 4,011 | $52.49 | $210,537.39 |
DisclosureSEC source: 0001104659-07-012311 · a4.xml · nonDerivative · entry 4 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,430 Read SEC document |
| February 17, 2007 Filed Feb 20, 2007 21:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 7,233 | $52.49 | $379,660.17 |
DisclosureSEC source: 0001104659-07-012311 · a4.xml · nonDerivative · entry 3 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,441 Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 21,000 | $52.54 | $1,103,340.00 |
DisclosureSEC source: 0001104659-07-012311 · a4.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,674 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 21:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 55,200 | $52.54 | $2,900,208.00 |
DisclosureSEC source: 0001104659-07-012311 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,674 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 02, 2007 Filed Feb 5, 2007 20:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,800 | $52.72 | $147,604.80 |
DisclosureSEC source: 0001104659-07-007161 · a4.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,474 Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 20:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 9,226 | $53.00 | $488,978.00 |
DisclosureSEC source: 0001104659-07-007161 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,274 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 23:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 55,000 | $44.16 | $2,428,800.00 |
DisclosureSEC source: 0001104659-06-011243 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,500 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 30,500 | $46.34 | $1,413,370.00 |
DisclosureSEC source: 0001104659-05-008011 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,500 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 28,000 | $43.66 | $1,222,480.00 |
DisclosureSEC source: 0001104659-04-005598 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16b under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.